Detalhe da pesquisa
1.
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
Catheter Cardiovasc Interv
; 98(6): 1111-1119, 2021 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33038061
2.
Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled Trials.
JACC Cardiovasc Interv
; 10(18): 1881-1890, 2017 09 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28935081
3.
5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
JACC Cardiovasc Interv
; 6(12): 1263-6, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24239202
4.
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years.
Am J Cardiol
; 110(1): 21-9, 2012 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22464212
5.
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
EuroIntervention
; 6 Suppl J: J44-52, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21930490
6.
Detection of Listeria monocytogenes from a model food by fluorescence resonance energy transfer-based PCR with an asymmetric fluorogenic probe set.
Appl Environ Microbiol
; 69(2): 1082-8, 2003 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-12571032